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Abstract
Objectives: As part of the Vanguard programme, two integrated care models were introduced in South Somerset for
people with complex care needs: the Complex Care Team and Enhanced Primary Care. We assessed their impact on a
range of utilization measures and mortality.
Methods: We used monthly individual-level linked primary and secondary care data from April 2014 to March 2018 to
assess outcomes before and after the introduction of the care models. The analysis sample included 564 Complex Care
Team and 841 Enhanced Primary Care cases that met specific criteria. We employed propensity score methods to
identify out-of-area control patients and difference-in-differences analysis to isolate the care models’ impact.
Results: We found no evidence of significantly reduced utilization in any of the Complex Care Team or Enhanced
Primary Care cohorts. The death rate was significantly lower only for those in the first Enhanced Primary Care cohort.
Conclusions: The integrated care models did not significantly reduce utilization nor consistently reduce mortality.
Future research should test longer-term outcomes associated with the new models of care and quantify their contri-
bution in the context of broader initiatives.
Keywords
long term conditions, integrated care, primary and hospital care systems
Introduction
Improvements in life expectancy1 are partly due to
better and more accessible health care.2 However,
although people are living longer, many are living
with at least one long term condition (LTC) requiring
ongoing health and social care support. Unless care is
integrated, patients may not be cared for in the most
appropriate setting or at the right time.
These demographic and system challenges face
South Somerset in the UK: over 20% of the popula-
tion is aged over 65 and around 4% consume 50% of
the health care resources.3 As one of the integrated
primary and acute care systems (PACSs)4 in the
English national Vanguard programme,5 two new
models of integrated care (IC) were introduced in
South Somerset.
The first IC model, the Complex Care Team (CCT),
provides senior medical input, care coordination, and a
personalized care plan to support self-care. Staffed by
GPs with expertise in chronic care management, com-
plex care nurses and other keyworkers, the CCTs aim
to prevent avoidable hospitalizations or, for those in
hospital, to support appropriate inpatient care.
In February 2015, a single CCT was set up, covering
the whole of South Somerset. CCT staff identified com-
plex patients already in hospital to support them there
and post-discharge. In August 2016 two additional
CCTs were established. GPs could either refer their
complex patients to the local CCT, or continue man-
aging them with CCT support. The latter model
became the norm in March 2017.
The second IC model, Enhanced Primary Care
(EPC), supports people with complex conditions to
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manage their own conditions, primarily through health
coaching. EPCs bring together primary care clinicians,
health coaches, musculoskeletal practitioners, pharma-
cists, and mental health workers.
Individuals with three or more LTCs from a list of
eight (cancer, chronic obstructive pulmonary disease,
dementia, stroke, cardiac problems, depression, diabe-
tes, chronic kidney disease) and/or a history of frequent
admissions were eligible for the CCT. These criteria
subsequently broadened to include patients’ social cir-
cumstances (information that is not routinely
recorded). EPC was initially targeted at people likely
to become future complex patients, usually those with
one or more LTC and/or fragility and/or a complex
social situation. Gradually, the distinction between
the CCT and EPC care models blurred into a care con-
tinuum, with EPC also acting as step-down care for
patients no longer needing CCT input.6
The care models were intended to support joint
working and ‘reduce reliance on hospital care’.4 In
this article, we assess the impact of the two models
(‘interventions’) on utilization and mortality.
Methods
Data
The study analysed pseudonymized patient-level pri-
mary and secondary care data from April 2014 to
March 2018, covering the entire Somerset population
and capturing information about each resident’s char-
acteristic, health care utilization, care home residency,
and date of death (if applicable). Those enrolled in the
CCT or EPC models can be identified, but intervention
costs are not reported.
Datasets were accessed as part of a Data Sharing
Agreement between the University of York and the
NHS South, Central and West Commissioning
Support.7
Cohorts
Evaluating the impact of the two IC models faced two
key challenges. Firstly, IC interventions and eligibility
criteria evolved over time, to ensure care was patient-
centered, and to facilitate ‘reflexive learning’.8 Thus, in
addition to evaluating the overall effects of CCT and
EPC, we also performed sub-group analyses of CCT
and EPC enrollees divided into 6-month cohorts to
assess whether effects varied as the interventions
evolved.
Secondly, patients were not randomized to the IC
interventions. We used propensity score matching tech-
niques to identify suitable controls and capture the
‘counterfactual’ – namely, what would have happened
in the absence of the IC intervention. Controls should
resemble cases in all relevant characteristics with the
exception that they are not exposed to the IC
intervention.
As it was intended that the two care models would
be rolled out to all eligible people in South Somerset,
matched controls were selected ‘out of area’, in other
parts of Somerset where these IC interventions were
not introduced.9,10 Table 1 shows the period covered
by each cohort and the period midpoint (columns
(2) and (4) respectively). In total, 661 CCT cases and
908 EPC cases had valid or imputed enrolment dates
(column (6)). Of those, 564 CCT cases and 841 EPC
cases were suitable for matching (column (7)).
Base case analysis. For each 6-month cohort, matching
variables capturing patient profiles at baseline were
used to derive a ‘propensity score’ for each individual
in Somerset.11 The score reflects the likelihood of being
exposed to the IC model, given a set of individual char-
acteristics. For each cohort, we based the matching
variables on the cohort midpoint and generated varia-
bles from monthly data. For both CCT and EPC, our
matching variables were: age, gender, socio-economic
status, a count of 8 LTCs, a count of GP visits in the
past 12months, a count of prescriptions received in the
past 12months, a ‘HealthNumerics-RISC score’,12 and
care home residency. Derived from demographic, clin-
ical and utilization data, the RISC score represents the
likelihood of inpatient admission over the next
12months and is calculated each month for everyone
in Somerset. The binary measure of care home residen-
cy captures individuals’ capacity for independent
living.
We used information corresponding to enrolment
criteria in undertaking matching and compared various
matching algorithms, opting for Single Nearest
Neighbour without replacement (see Appendix 1
online). The propensity scores are estimated for the
South Somerset population using logistic regression
and then predicted for the population in the other
areas of Somerset that were not exposed to the inter-
ventions (see Appendix 1 online).
We employed a ‘difference in differences’ (DiD)
regression approach (Appendix 1 online) that includes
a single IC intervention, and pre- and post-enrolment
periods to compare the utilization of the matched
cohorts of cases and controls. By comparing matched
cases and controls over time, the DiD evaluative
approach isolates differences attributable to the inter-
vention from underlying trends.
Matched controls may have been exposed to other
forms of IC intervention in other parts of Somerset.
If so, this would violate the assumption that changes
in utilization for controls reflect only general time
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trends.13 Our analysis therefore controls for the
Somerset Practice Quality Scheme (SPQS), introduced
in 2014 to encourage multi-disciplinary working in gen-
eral practice.14
Sensitivity analyses. There are two reasons why cases and
controls may not be well-matched. First, there is con-
siderable variation among cases in terms of complexity,
diagnosis, and care needs. If those enrolled were close
to death, and died between enrolment and follow up,
they were no longer at risk of an ‘event’ such as a hos-
pital admission. Including the zero or low utilization of
those who died reduces the mean value in their cohort.
In recognition of this potential bias, we performed a
robustness check in the form a DiD for the subgroup of
survivors (only) by matching survivors in the interven-
tion group to comparable (surviving) controls.
Second, some patients may have been exposed to
both IC models. To account for the possibility of cross-
over, we tested the impact of prior use of CCT in a
sensitivity analysis.
All analyses were conducted in Stata Statistical
Software: Release 14.
Service utilization measures. The analysis tests for the
effect of CCT and EPC on a range of service utilization
measures, all based on monthly values. For CCT, there
are five measures: outpatient visits, accident and emer-
gency (A&E) attendances, emergency admissions, bed
days, and the total cost of primary, community and
hospital care. For EPC, there are three measures:
acute inpatient admissions, acute outpatient admis-
sions, and the costs of primary care and community
care as a proportion of total cost.
Figures 1 and 2 show trends in utilization for the
CCT and EPC cohorts, with the vertical lines and shad-
ing indicating the evaluation periods. In Figure 1, all
utilization measures are shown on a scale of 0 to 1,
except for bed days (0 to 5) and total monthly costs
(£0 to £3000). In Figure 2, acute outpatient visits and
acute admissions are shown on a scale of 0 to 0.5 and
the proportion of total costs spent on out-of-hospital
care is shown on a scale of 0 to 1. For the analysis,
outcomes are aggregated over the relevant period. We
applied a standardized follow-up period for each
cohort, as is usual evaluative practice. For most
cohorts, the period is 12months pre and 12months
post the 6-month window. For the fifth CCT cohort
and the second EPC cohort, the periods are each
7months due to limited follow-up data (Table 1).
Results
Balance graphs
In all CCT and EPC cohorts, matching worked well in
terms of the baseline (midpoint) comparability of cases
and controls on the matching variables. Descriptive
statistics and balance graphs are in Appendix 2 online.
Table 1. Overview of the intervention cohorts.
Six-month
cohort Cohort period
PRE period
for DiD†
Cohort
midpoint^
POST period
for DiD†
Cases with
valid or
imputed
enrolment
date
Cases used
for matching&
(1) (2) (3) (4) (5) (6) (7)
CCT1 22 Feb 2015–21 Aug 2015 Apr 2014–Feb 2015 22 May 2015 Sept 2015–July 2016 96 86
CCT2 22 Aug 2015–21 Feb 2016 Sept 2014–Aug 2015 22 Nov 2015 Mar 2016–Feb 2017 53 47
CCT3 22 Feb 2016–21 Aug 2016 Mar 2015–Feb 2016 22 May 2016 Sept 2016–Aug 2017 99 90
CCT4 22 Aug 2016–21 Feb 2017 Sept 2015–Aug 2016 22 Nov 2016 March 2017–Feb 2018 266 209
CCT5 22 Feb 2017–21 Aug 2017 Aug 2016–Feb 2017 22 May 2017 Sept 2017–March 2018 150 132
CCT – total 661 564
EPC1 01 Sep 2016–28 Feb 2017 Sep 2015–Aug 2016 01 Dec 2016 Mar 2017–Feb 2018 662 603
EPC2 01 Mar 2017–30 Aug 2017 Aug 2016–Feb 2017 01 June 2017 Sep 2017–March 2018 246 231
EPC – total 908 841
^Matching at this point.
†The matching variables are based on monthly data, so the baseline measures used for matching are closely aligned with patients’ enrolment date.
Because data were available from April 2014 to March 2018, the pre-enrolment and post-enrolment periods used for the DiD analysis were shorter
than 12months for cohorts CCT1, CCT5 and EPC2: 11months for CCT1; (March 2014 not available); and 7months for CCT5 and EPC2 (April 2018
and onwards not available).
&Numbers differ from previous column due to exclusions. Individuals were excluded if: there was a discrepancy between date of death and date of
enrolment; the patient record was incomplete in the pre-enrolment period; matching variables were missing from the monthly datasets (and could not
be imputed); intervention cases lived outside of South Somerset; or if individuals were aged<18. In the initial enrolment period patients were recruited
on hospital wards and their enrolment date was not recorded. We assigned these cases to the CCT1 on advice of local advisors.
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Figure 1. Utilization for CCT cohorts.
Figure 2. Utilization for EPC cohorts.
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Impact on utilization
Table 2 reports the impact for the five CCT cohorts
in turn, together with a pooled analysis that
assesses the overall impact of the CCT intervention.
The pooled analysis has the advantage of including
all CCT cases and controls, but assumes that cases
were exposed to the same form of CCT, ignoring its
evolution.
Each DiD equation contains four key variables that
disentangle general temporal changes (POST), differ-
ences between the control and treatment groups (IC),
the impact of the care models (DiD), and the effect of
the SPQS scheme (SPQS).
First, utilization or costs may change over time irre-
spective of the introduction of the CCT intervention.
These general temporal changes are captured by the
POST variable, which is always negative and often sig-
nificant. The pooled analysis shows that a significant
decline (P< 0.001) in utilization and costs occurred
independently of the CCT intervention.
Second, the variable IC captures differences in utili-
zation in the pre-enrolment period between the case
and control groups. Such differences may reflect imper-
fect matching, and the IC variables account for this
possibility. The pooled analysis shows that CCT cases
had significantly higher utilization and costs than con-
trols in the pre-enrolment period. Cases had more
outpatient visits in CCT1 (P¼ 0.006) and CCT2
(P¼ 0.013), higher total costs in CCT3 (P¼ 0.022),
more non-elective admissions in CCT4 (P¼ 0.023)
and CCT5 (P¼ 0.011) and more A&E attendances in
CCT5 (P¼ 0.011).
Third, the variable DID captures the variable of
policy interest: the impact of the CCT intervention on
utilization or costs, after accounting for time trends
and pre-enrolment differences with the controls.
Table 2. DiD results for utilization: CCT cohorts.
Acute Outpatient visits A&E attendances Non-elective admissions Bed days Total cost
Coef P Coef P Coef P Coef P Coef P
Cohort 1 (N¼ 344)^
POST –2.16 0.016 –0.72 0.057 –0.59 0.028 –8.34 0.030 –5363 0.005
IC 2.54 0.006 0.56 0.153 0.34 0.218 2.17 0.581 3393 0.086
DiD 0.04 0.978 0.50 0.349 0.41 0.284 12.16 0.025 3782 0.164
SPQS 0.35 0.703 –0.04 0.925 –0.21 0.431 –1.69 0.661 –429 0.825
Cohort 2 (N¼ 188)^
POST –1.26 0.401 –0.51 0.415 –0.62 0.212 –7.11 0.191 –2912 0.317
IC 3.87 0.013 0.84 0.192 0.56 0.268 0.12 0.982 4005 0.182
DiD –0.57 0.786 0.23 0.791 1.06 0.129 12.87 0.095 4128 0.316
SPQS 1.33 0.483 –0.07 0.933 –0.17 0.790 2.02 0.770 4296 0.246
Cohort 3 (N¼ 360)^
POST –1.93 0.133 –0.93 0.014 –0.74 0.031 –5.97 0.037 –3280 0.093
IC 2.38 0.075 0.36 0.359 0.48 0.181 3.14 0.289 4658 0.022
DiD 2.63 0.148 0.30 0.574 0.37 0.451 2.56 0.526 3100 0.262
SPQS 1.41 0.326 0.12 0.769 –0.18 0.643 3.27 0.304 1305 0.549
Cohort 4 (N¼ 836)^
POST –1.25 0.025 –0.51 0.047 –0.49 0.010 –3.41 0.080 –3312 0.017
IC 1.08 0.063 0.48 0.074 0.45 0.023 3.63 0.073 2195 0.127
DiD 1.20 0.128 –0.11 0.762 0.06 0.830 1.17 0.670 5595 0.004
SPQS –0.59 0.361 0.00 0.995 –0.23 0.290 1.18 0.604 –1778 0.269
Cohort 5 (N¼ 528)^
POST –1.25 0.086 –0.35 0.273 –0.32 0.154 –4.70 0.060 –3156 0.021
IC 1.13 0.132 0.83 0.011 0.59 0.011 3.66 0.155 981 0.486
DiD –0.74 0.471 –0.27 0.555 –0.24 0.442 –2.00 0.571 1762 0.361
SPQS 0.76 0.401 –0.33 0.399 –0.28 0.309 0.02 0.495 249 0.883
Pooled (N¼ 2256)^
POST –1.50 <0.001 –0.57 <0.001 –0.52 <0.001 –5.18 <0.001 –3550 <0.001
IC 1.77 <0.001 0.59 <0.001 0.48 <0.001 3.12 0.018 2670 0.001
DiD 0.65 0.241 0.04 0.853 0.17 0.301 3.30 0.066 3901 <0.001
SPQS 0.25 0.584 –0.07 0.714 –0.24 0.083 0.60 0.683 –339 0.709
Note: significant (P< 0.05) results in bold. N is the number of observations (4 observations per patient).
^N is the number of observations used in the regression and equals four times the number of cases in the cohort (see column 7, Table 1): outcomes for
cases and matched controls are observed pre-enrolment and post-enrolment.
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The pooled analysis found no significant impact of the
CCT intervention on utilization but CCT cases had
significantly higher costs than the controls
(P< 0.001). Bed days were significantly higher for
cases in CCT1 (P¼ 0.025) and costs were significantly
higher for cases in CCT4 (P¼ 0.004).
Fourth, the variable SPQS captures the effect of the
Somerset Practice Quality Scheme. This scheme had no
significant effect on any utilization measure.
Table 3 shows the impact of the EPC intervention
on utilization for the two EPC cohorts, and a pooled
analysis featuring all EPC cases and controls. In the
pooled analysis, the proportion of out-of-hospital
costs fell over time (POST P< 0.001) and, pre-
enrolment, cases had more outpatient visits
(IC P< 0.001) and a higher proportion of out-
of-hospital costs (IC P< 0.001) than controls. The
non-significant DiD coefficients indicate that the EPC
intervention had no impact on utilization or costs, and
neither did the SPQS arrangements.
Impact on mortality
Table 4 reports the analysis of mortality. The only sig-
nificant differences were for CCT5, where the mortality
rate of cases was higher (P¼ 0.002), and for EPC1
where the mortality rate of cases was lower (P¼ 0.003).
Sensitivity analyses
There is considerable variation in death rates across
cohorts and between cases and controls (see
Appendix 3, Table A3.1, and Figures A3.1 and A3.2,
all online).
In general, the analysis of the subgroup of survivors
supported findings from the main analyses (Appendix
3, Tables A3.2-A3.4, online).
Table A3.5 in Appendix 3 online shows the results
accounting for prior use of CCT on EPC patients. In
the EPC1 cohort, there were three significant differen-
ces. For the subgroup of cases that used both CCT and
EPC (captured by DiD-dual), acute inpatient use was
higher (P¼ 0.002) and the proportion of out-of-
hospital costs was lower (P¼ 0.017) compared with
controls. The remaining EPC patients (captured by
DiD) had a significantly higher proportion of out-of-
hospital costs (P¼ 0.001) than controls. There was no
effect of prior CCT use on utilization in EPC2 cohort.
Discussion
Establishing the impact of IC models is challenging if
the intervention is not subject to a randomized con-
trolled trial. Challenges also arise because the nature,
purpose and target population of the IC intervention
are difficult to define and evolve over time.13
To tackle these challenges, we used propensity score
matching to identify out-of-area controls and divided
enrollees into 6-monthly cohorts in recognition of the
evolving nature of the care models and changes in the
characteristics of enrollees. We employed DiD analysis
to capture the impact of the intervention and to
account for time trends.
Table 3. DiD results for utilization: EPC cohorts.
Acute inpatient Acute outpatient
Proportion of
out-of-hospital costs
Coef P Coef P Coef P
Cohort 1 (N¼ 2412)^
POST –0.28 0.150 –0.56 0.086 –1.23 <0.001
IC 0.26 0.203 1.32 <0.001 1.78 <0.001
DiD 0.49 0.075 0.62 0.181 0.55 0.068
SPQS 0.06 0.796 0.27 0.467 –0.37 0.134
Cohort 2 (N¼ 924)^
POST –0.03 0.770 –0.44 0.134 –0.26 0.097
IC 0.03 0.772 0.44 0.154 0.36 0.031
DiD 0.02 0.863 0.30 0.462 0.25 0.263
SPQS 0.14 0.154 –0.17 0.590 –0.07 0.674
Pooled (N¼ 3336)^
POST –0.21 0.145 –0.53 0.037 –0.96 <0.001
IC 0.19 0.211 1.05 <0.001 1.34 <0.001
DiD 0.36 0.076 0.53 0.138 0.47 0.082
SPQS 0.11 0.516 0.20 0.475 –0.10 0.657
Note: significant (p< 0.05) results in bold. N is the number of observations (4 observations per patient).
^N is the number of observations used in the regression and equals four times the number of cases in the cohort (see column 7, Table 1): outcomes for
cases and matched controls are observed pre-enrolment and post-enrolment.
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We found no robust evidence that either interven-
tion significantly reduced utilization during the 12-
month follow-up period. Rather, cases had significantly
more bed days in CCT1, and costs were higher in CCT4
compared with controls. There was no conclusive evi-
dence that the care models had an impact on mortality.
International reviews of integrated care support our
findings, with limited evidence of impacts on utilization
or costs.15,16
Limitations
Our findings should be interpreted with caution. First,
there are concerns about the comparability of cases and
controls. Differences in death rates across controls and
cases may reflect systematic unobserved differences in
severity. Consequently, our findings may underestimate
the true impact of the care models.
Second, this evaluation is of evolving care models
during their developmental stages and follow up was
limited to 12months for each cohort.
Third, although we were able to account for the
SPQS, other less formalized integrated care initiatives
may also have been operating. Data about these initia-
tives is lacking but circumstantial evidence suggests
they may have contributed to reduced non-elective
inpatient admissions.17
Nonetheless, our findings do not validate the logic
underpinning the new care models – namely, that inte-
grating care reduces hospital utilization.
Conclusion
Our analysis found no evidence that either IC interven-
tion significantly reduced utilization over the 12-month
follow-up period, and no consistent evidence that the
care models had an impact on mortality. However, this
was not an effectiveness study of fully-fledged integrat-
ed models of care. Future research should test longer-
term outcomes associated with the new models of care
and quantify their contribution in the context of
broader initiatives.
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